Health Care: Drugs

Gilead Sciences Inc (GILD: NASDAQ)

$106.57 0.21 | 0.2%
11/24/15 - 04:00 PM ET
Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 12.06B 3.06B 2.57B 2.79B
Operating Gains/Losses 0.00 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -2.58B -315.30M 197.99M -375.74M
(Increase) Decrease in Inventories 143.00M -343.14M -349.92M -200.79M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -289.00M -97.67M 117.48M 428.94M
(Decrease) Increase In Other Current Liabilities 2.55B 341.65M 317.59M 411.36M
(Increase) Decrease In Other Working Capital 31.00M 22.14M 23.25M -29.48M
Other Non-Cash Items 463.00M 363.86M 205.24M 263.32M
Net Cash From Continuing Operations 12.82B 3.10B 3.19B 3.64B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 12.82B 3.10B 3.19B 3.64B
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 859.00M 0.00 0.00 9.44B
Purchases of Property, Plant & Equipment -557.00M -190.78M -397.05M -131.90M
Acquisitions 0.00 -378.64M -10.75B -588.61M
Purchases of Short-Term Investments -2.11B -256.70M -1.24B -5.13B
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -1.82B -254.35M -11.85B 3.59B
Issuance of Debt 10.47B 2.77B 2.36B 4.66B
Cash Used for Financing Activities
Issuance of Capital Stock 331.00M 313.08M 466.28M 211.74M
Repayment of Long-Term Debt -4.80B -4.44B -1.84B -651.55M
Repurchase of Capital Stock -5.35B -582.36M -667.04M -2.38B
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -3.68B -609.17M 244.84M -74.19M
Net Cash From Financing Activities -3.02B -2.54B 563.35M 1.76B
Effect of Exchange Rate Changes -56.00M 2.42M 7.91M -16.53M
Net Change in Cash & Cash Equivalents 7.91B 309.11M -8.08B 8.98B

Portfolios with GILD

Latest GILD Headlines from TheStreet

More Financial News for GILD

Press Releases for GILD

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter